These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2637 related items for PubMed ID: 26250831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA, Vere CC, Rogoveanu I, Streba CT.
    World J Gastroenterol; 2015 Apr 14; 21(14):4103-10. PubMed ID: 25892859
    [Abstract] [Full Text] [Related]

  • 3. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.
    Pocha C, Kolly P, Dufour JF.
    Semin Liver Dis; 2015 Aug 14; 35(3):304-17. PubMed ID: 26378646
    [Abstract] [Full Text] [Related]

  • 4. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
    Oda K, Uto H, Mawatari S, Ido A.
    Clin J Gastroenterol; 2015 Feb 14; 8(1):1-9. PubMed ID: 25575848
    [Abstract] [Full Text] [Related]

  • 5. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp AC, Choti MA.
    Dig Dis; 2015 Sep 14; 33(5):642-7. PubMed ID: 26398208
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O, Charlton M.
    Clin Liver Dis; 2018 Feb 14; 22(1):201-211. PubMed ID: 29128057
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Fukusato T.
    World J Gastroenterol; 2014 Nov 14; 20(42):15539-48. PubMed ID: 25400438
    [Abstract] [Full Text] [Related]

  • 9. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH.
    Am J Surg Pathol; 2010 Nov 14; 34(11):1630-6. PubMed ID: 20975341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P, Davidsdottir L, Oksanen A, Isaksson B, Hultcrantz R, Stål P.
    Liver Int; 2015 Jul 14; 35(7):1862-71. PubMed ID: 25524812
    [Abstract] [Full Text] [Related]

  • 12. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.
    Margini C, Dufour JF.
    Liver Int; 2016 Mar 14; 36(3):317-24. PubMed ID: 26601627
    [Abstract] [Full Text] [Related]

  • 13. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
    Loomba R, Lim JK, Patton H, El-Serag HB.
    Gastroenterology; 2020 May 14; 158(6):1822-1830. PubMed ID: 32006545
    [Abstract] [Full Text] [Related]

  • 14. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B, Shah V, Onyshchenko M, Elshamy M, Aucejo F, Lopez R, Hanouneh IA, Alhaddad R, Alkhouri N.
    Hepatol Int; 2016 Jul 14; 10(4):632-9. PubMed ID: 26558795
    [Abstract] [Full Text] [Related]

  • 15. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
    Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ.
    Hepatology; 2018 Jan 14; 67(1):123-133. PubMed ID: 28802062
    [Abstract] [Full Text] [Related]

  • 16. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S, Kienbacher C, Halilbasic E, Rechling C, Kazemi-Shirazi L, Hofer H, Munda P, Trauner M.
    Dig Dis; 2015 Jan 14; 33(4):598-607. PubMed ID: 26159280
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S.
    Transplantation; 2019 Jan 14; 103(1):22-27. PubMed ID: 30335697
    [Abstract] [Full Text] [Related]

  • 18. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO, Ferreira FG, Nascimento Mde F, Vieira A, Ribeiro MA, David AI, Szutan LA.
    World J Gastroenterol; 2015 Jan 21; 21(3):913-8. PubMed ID: 25624725
    [Abstract] [Full Text] [Related]

  • 19. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E, Paul SB, Kedia S.
    Indian J Med Res; 2019 Jan 21; 149(1):9-17. PubMed ID: 31115369
    [Abstract] [Full Text] [Related]

  • 20. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
    Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Waterworth DM, Kendrick S, Sattar N, Alazawi W.
    BMC Med; 2019 May 20; 17(1):95. PubMed ID: 31104631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 132.